StocksFin Logo
Eli Lilly and Company country of incorporation
|
|
Mr. David Ricks
|
35,000 employees
NYSE | Healthcare | Drug Manufacturers—General
Thermo Fisher Scientific Inc. country of incorporation
|
|
Mr. Marc Casper
|
130,000 employees
NYSE | Healthcare | Diagnostics & Research
Q322 reported Nov 1, 2022 Reporting Period
$6.94B 2.5% vs. Q321 Revenues Q322
77.25% -2.1% vs. Q321 Gross Profit Margin
20.91% 27.6% vs. Q321 Net Profit Margin
1.56B -4.1% vs. Q321 Free Cash Flow Q322
$1.61 38.7% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.3%
Q322
0.21%
Q322 reported Nov 4, 2022 Reporting Period
$10.68B 14.4% vs. Q321 Revenues Q322
40.29% -19.2% vs. Q321 Gross Profit Margin
14% -31.3% vs. Q321 Net Profit Margin
1.39B -47.5% vs. Q321 Free Cash Flow Q322
$3.82 -20.9% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.3%
Q322
0.21%
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Dec 31, 2022
Quick Ratio
0.71
0.98
Current Ratio
1.13
1.48
Cash Ratio
0.17
0.5
Price to Book
28.92
5.02
Price to Sales
41.96
4.92
Price to Earnings
50.16
31.83